UNSPSC 51131644: Melagatran

This classification denotes an anticoagulant agent with the molecular formula C22H31N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2A9QP32MD4, chemically known as glycine, n-(2-(2-((((4-(aminoiminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-1-cyclohexyl-2-oxoethyl)-, (s-(r*,s*))- but generally known as melagatran, which bears US NIH Compound Identifier 183797. European Medicines Agency schedules Melagatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08718MIG.

UNSPSC 51131644 Melagatran is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The single recent opportunity — Sourcewell RFP #061626, posted May 12, 2026 with a June 16, 2026 response deadline — seeks law enforcement equipment through a cooperative purchasing vehicle serving thousands of governmental agencies, K-12 school districts, higher education institutions, nonprofit organizations, tribal governments, and other public entities across the United States and Canada. Melagatran is a pharmaceutical anticoagulant with no apparent relevance to law enforcement equipment procurement, indicating a tagging mismatch between the code designation and the actual work being solicited.

The code shows little relevant recent activity. Sourcewell, a State of Minnesota local government unit and service cooperative, is administering the RFP on behalf of participating entities including Franklin, Grant, Grays Harbor, Chelan, and Yakima Counties in Washington and numerous other jurisdictions. Proposals must be submitted through the Sourcewell Procurement Portal at https://proportal.sourcewell-mn.gov by June 16, 2026 at 3:30 p.m. Central Time. No set-aside designations, award values, or budget ranges are identified in the available documentation. The resulting contract establishes a framework agreement available for use by participating addendum across the Sourcewell cooperative network, but the pharmaceutical nature of the code does not track with the law enforcement equipment scope of the actual opportunity.